Safety and Efficacy of Stem Cell Therapy in Patients With Autism

Inclusion Criteria: * Children between the ages of 3 and 12 years. * DSM-IV diagnosis of Autistic Disorder. * Total score of CARS ≥ 30. * Parents or legal guardian willing to sign the ICF. Exclusion Criteria: * Any history of hypersensitivity to serum products, or other known drug and food allergy. * History of prior or current DSM-IV psychotic disorder (e.g., schizophrenia, bipolar disorder, other psychosis), Pervasive Developmental Disorder not otherwise specified (PDD NOS), Asperger's, or Rett's. * History of Epileptic seizure activity in the past 6 months. * Autism caused by seizure disorders (active), cerebrovascular disease or brain trauma. * The global autism ratings are assessed as being absent, minimal or mild. * Existing moderate or severe extrapyramidal symptoms (EPS) or history of tardive dyskinesia. * Subjects who have displayed significant self-injurious behavior (children who have caused visible harm to themselves). * HIV+ * Acute and chronic hepatitis. * Autoimmune disease, e.g. lupus erythematosus, multiple sclerosis. * Severe pulmonary and hematological disease, malignancy or hypo-immunity. * Currently undertaking other treatment that may affect the safety/efficacy of stem cells. * Enrollment in other trials in the last 3 months. * Other criteria the investigator consider improper for inclusion.